Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A three‐signal model of T‐cell lymphoma pathogenesis
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 113-122
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2017) Vol. 92, Iss. 10, pp. 1085-1102
Open Access | Times Cited: 141
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2019) Vol. 94, Iss. 9, pp. 1027-1041
Open Access | Times Cited: 117
Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma
M. Fujisawa, Mamiko Sakata‐Yanagimoto, Shoko Nishizawa, et al.
Leukemia (2017) Vol. 32, Iss. 3, pp. 694-702
Open Access | Times Cited: 114
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
Rebecca L. Boddicker, Gina L. Razidlo, Surendra Dasari, et al.
Blood (2016) Vol. 128, Iss. 9, pp. 1234-1245
Open Access | Times Cited: 108
Peripheral T cell lymphomas: from the bench to the clinic
Danilo Fiore, Luca Vincenzo Cappelli, Alessandro Broccoli, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 6, pp. 323-342
Closed Access | Times Cited: 105
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
F. Amatore, Laurent Gorvel, Daniel Olive
Expert Opinion on Biological Therapy (2019) Vol. 20, Iss. 2, pp. 141-150
Closed Access | Times Cited: 88
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 51
Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy
F. Amatore, Laurent Gorvel, Daniel Olive
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 4, pp. 343-351
Closed Access | Times Cited: 79
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma
Matthew J. Maurer, Fredrik Ellin, Line Srour, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 36, pp. 4019-4026
Open Access | Times Cited: 60
T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy
Tianjiao Wang, Ye Lu, Avery Polk, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 10, pp. 2506-2515
Open Access | Times Cited: 53
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability
Carlos Murga‐Zamalloa, Delphine C.M. Rolland, Avery Polk, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 3, pp. 690-703
Open Access | Times Cited: 52
Pathogenesis of Peripheral T Cell Lymphoma
Marco Pizzi, Elizabeth Margolskee, Giorgio Inghirami
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 13, Iss. 1, pp. 293-320
Open Access | Times Cited: 47
The new biology of PTCL‐NOS and AITL: current status and future clinical impact
Matthew A. Timmins, Simon D. Wagner, Matthew J. Ahearne
British Journal of Haematology (2020) Vol. 189, Iss. 1, pp. 54-66
Open Access | Times Cited: 45
Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2021) Vol. 96, Iss. 10, pp. 1313-1328
Open Access | Times Cited: 38
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 37
Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity
Kohsuke Shirakawa, Motoaki Sano
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
PTCL, NOS: An update on classification, risk-stratification, and treatment
J. Weiss, John Reneau, Ryan A. Wilcox
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis
Rituparna Chakrabarti, Bhavya Kapse, Gayatri Mukherjee
Cancer Reports (2019) Vol. 2, Iss. 4
Open Access | Times Cited: 41
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
Haematologica (2019) Vol. 105, Iss. 2, pp. 435-447
Open Access | Times Cited: 40
Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2020) Vol. 95, Iss. 10, pp. 1209-1213
Open Access | Times Cited: 38
FYN–TRAF3IP2 induces NF-κB signaling-driven peripheral T-cell lymphoma
Christine S. Moon, Clara Reglero, José R. Cortés, et al.
Nature Cancer (2021) Vol. 2, Iss. 1, pp. 98-113
Open Access | Times Cited: 28
Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents
Sumana Devata, Ryan A. Wilcox
American Journal of Clinical Dermatology (2016) Vol. 17, Iss. 3, pp. 225-237
Closed Access | Times Cited: 34
Follicular Helper CD4+ T Cells, Follicular Regulatory CD4+ T Cells, and Inducible Costimulator and Their Roles in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Xue Zhang, Ruli Ge, Hongliang Chen, et al.
Mediators of Inflammation (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 24
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
Xiangrong Geng, Chenguang Wang, Xin Gao, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top